Paul is the President of the British Association for Cytopathology and is currently a Consultant Cellular Pathologist, reporting both histology and a wide range of cytology. Paul has over 35 years of experience in pathology, and have a main interest in gynaecological pathology, cervical cytology and diagnostic cytology. He has 85+ published papers and several book chapters, and have contributed to or led on the production of numerous cytology guidances in the UK. Paul has helped develop the UK NEQAS diagnostic cytology technical EQA scheme, and is now helping develop a digital cytology interpretative EQA scheme also. He has been lead on several RCPath Cytology guidance documents, including the Tissue Pathways for diagnostic Cytopathology document.

Ryan is an ST3 trainee pathologist in the North East of England currently in the Royal Victoria Infirmary Newcastle and completed his audit in Queen Elizabeth Hospital Gateshead under the supervision of Dr Paul Cross. As a trainee he must remain interested in all pathology but he particularly enjoys cytopathology, lung, endocrine and urological surgical pathology.

Leonie is a Senior Biomedical Scientist in Cytopathology at the Royal Cornwall Hospital (RCHT), currently training for my advanced specialist diploma in non gynaecological cytopathology.

Leonie began participating in ROSE in 2005 for bronchial brushings, Wang technique fine needle aspirations and head and neck FNA at Queen Marys Hospital South London NHS trust.

In 2010 she moved back home to Cornwall. Endoscopic Ultrasound (EUS) and Endobronchial ultrasound (EBUS) services were in their infancy at this time, providing a great opportunity to implement rapid on site evaluation (ROSE) services. Since 2010 the ROSE service has expanded successfully to cover, EBUS, EUS mediastinal, pancreas, liver, adrenal and gastrointestinal and ROSE for Head and Neck FNA. The EBUS and EUS mediastinal clinics are supported by three Biomedical Scientists (BMS), with another BMS in training to cover pancreas.

RCHT is home of the Single Slide Assessment (SSA), a highly effective technique for ROSE. We recognised that clinical procedures were becoming minimally invasive, resulting in smaller yields of diagnostic sampling. At the same time advances in molecular testing and personalised therapies required more from these smaller samples. This is the arena where ROSE truly makes a difference and I’m so happy to continue to be a part of it.

Nardira is a consultant Biomedical Scientist in the cytology department of Manchester Foundation Trust. She reports on both cervical and non gynaecological cytology and also lead the cytology section of the Urology MDT.

Originally from Anglesey, Gareth have been living in Cardiff since 1994, when he started studying for my medical degree. Gareth have been a Consultant Histopathologist since 2009, and have been at the University Hospital of Wales, Cardiff, throughout this time. His main interest is gynaecological pathology, as well as skin, non-gynae cytopathology, cervical cytology and biomarking. Since 2016 he has been Chair of the RCPath Working Group that is updating the Staffing and Workload document from the Royal College of Pathologists. We submitted a document for feedback by the Fellows earlier this year, and the final publication of the 5^th edition is expected no later than 31^st July, 2020.

Emma is currently working as an ST5 in Histopathology, pursuing subspecialist interests in cytology, lymphoma, urology and breast pathology. Born and raised in Belfast, in 2006 Emma moved to Devon to take up a place at medical school and have remained in the South West of England ever since. Alongside clinical training, Emma has fostered an interest in medical education, completing a Masters in Clinical Education with Distinction in 2017. This research was short-listed for, and ultimately awarded, the 2018 Best Original Research Paper Award by the Association for the Study of Medical Education (ASME). Emma is looking forward to developing future educational interventions within pathology.

I have been a consultant cytopathologist at Aberdeen Royal Infirmary for 26 years, reporting a full range of diagnostic cytology and cervical cytology as well as performing FNAs at breast, head and neck and thyroid clinics. I am the clinical lead for the Scottish Cervical Cytology EQA scheme. As a member of the BAC executive, I have the opportunity to help to promote cytology, and being an associate editor of Cytopathology helps to keep me up to date. I am an RCPath examiner, contributing to the cytology component of the FRCPath part2 exam for quite a few years and very recently, have taken over the role of lead organiser for this. I enjoy contributing to cytology training of histopathology trainees, am keen to promote cytology generally and would like cytology training to equip trainees to be confident to report and recommend cytology as appropriate in their future consultant practice. Dr Smart has been a consultant cytopathologist at Aberdeen Royal Infirmary for 26 years, reporting a full range of diagnostic cytology and cervical cytology as well as performing FNAs at breast, head and neck and thyroid clinics. She is the clinical lead for the Scottish Cervical Cytology EQA scheme. As a member of the BAC executive, she has the opportunity to help to promote cytology, and being an associate editor of Cytopathology helps to keep her up to date. Dr Smart is an RCPath examiner, contributing to the cytology component of the FRCPath part2 exam for quite a few years and very recently, has taken over the role of lead organiser for this. She enjoys contributing to cytology training of histopathology trainees, is keen to promote cytology generally and would like cytology training to equip trainees to be confident to report and recommend cytology as appropriate in their future consultant practice.

Robbie is the Head Biomedical Scientist for the Department of the Cellular & Molecular Pathology in the Northern Health and Care Trust. He has a strong passion for Innovation and Quality Improvement, and developing new diagnostic services. He started is career with the introduction of Human papilloma virus testing on gels before introducing the second generation high throughput testing platforms. This started the journey into Molecular Pathology and using cytology samples to better improve the patient testing pathway. Now with the changes in HPV primary testing, the introduction of Next Generation testing, and the start of Digital Pathology the journey is changing.